Bruker buys SPIM start-up
Image of MuVi-SPIM: a light-sheet microscope developed at EMBL and commercialised by Luxendo. [Luxendo]
Bruker, US, has acquired Germany-based Luxendo, a spin-off of The European Molecular Biology Laboratory and supplier of light sheet microscopes based on Single Plane Illumination Microscopy.
SPIM is a fluorescence microscopy technique that uses a focused light-sheet to illuminate the specimen from the side
The technology enables scientists to study entire living organisms in detail, thanks to its ability to rapidly image large, 3D samples with minimal damage.
To make this technology available to the scientific community, EMBL and its technology transfer arm, EMBLEM Technology Transfer, created Luxendo as a spin-off company in 2015, with seed financing from EMBL Ventures and Life Science Partners (LSP).
The spin-off's first two products, MuVi-SPIM and InVi-SPIM were launched in 2016.
"It has been very rewarding to witness the rapid trajectory from pioneering technology developed at EMBL to Luxendo's well-designed, robust microscopes, and now this acquisition," said EMBL Director General Iain Mattaj.
"We anticipate that Bruker... will make SPIM even more widely available," he adds. "It will be truly exciting to see what the larger biological research community will discover with light-sheet microscopy."
Dr Mark R. Munch, President of the Bruker NANO Group highlights Luxendo's rapid rise in the light-sheet microscopy market.
"We feel that we can take the business to the next level in both global market reach and next-generation development, which should greatly benefit our life sciences research customers," he says.
Learn more here